Categories: News

Accolade to Announce Fiscal Second Quarter 2022 Financial Results

SEATTLE, Sept. 16, 2021 (GLOBE NEWSWIRE) — Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal second quarter 2022 financial results on Thursday, October 7, 2021, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Conference Call Details

The conference call can be accessed by dialing 1-833-519-1281 for U.S. participants, or 1-914-800-3853 for international participants, referencing conference ID # 9547326; or via a live audio webcast that will be available online at http://ir.accolade.com.

A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Accolade, Inc.

Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Accolade helps millions of people and their employers navigate the complexities of the healthcare system with empathy, expertise and through exceptional service while supporting them in lowering the cost of care and improving health outcomes. Accolade blends technology-enabled health and benefits solutions, specialized support from Accolade Health Assistants® and Clinicians, and access to expert medical opinion services and virtual primary care. Accolade consistently receives consumer satisfaction ratings over 90 percent. For more information, visit Accolade on LinkedIn, Twitter, Instagram and Facebook and at accolade.com.

Investor Contact:

Todd Friedman, Investor Relations, 484-532-5200, IR@accolade.com

Asher Dewhurst, Investor Relations, 443-213-0500, accolade@westwicke.com

Media Contact:

Megan Torres, Public Relations, 206-926-8180, media@accolade.com

Source: Accolade 

Staff

Recent Posts

PreveCeutical Announces Up-Sized Non-Brokered Private Placement

Vancouver, British Columbia--(Newsfile Corp. - April 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB:…

6 hours ago

10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025

PLEASANTON, Calif., April 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell…

10 hours ago

Lifetech Resources CEO Shaffiq Rahim Delivers Keynote at 2025 Moorpark Chamber of Commerce Momentum and Impact Dinner

MOORPARK, Calif., April 14, 2025 /PRNewswire/ -- Lifetech Resources is proud to announce that its…

10 hours ago

BlackDoctor.org Appoints Akinwole (Aki) Garrett as President & COO to Lead Next Phase of Growth

CHICAGO, April 14, 2025 /PRNewswire/ -- BlackDoctor.org (BDO), the nation's leading health and wellness destination…

10 hours ago

ACR Statement on JAMA CT Scan Radiation Study (Smith-Bindman, et al)

RESTON, Va., April 14, 2025 /PRNewswire/ -- The theoretical radiation risk proposed by Smith-Bindman, et…

10 hours ago

Minutes of IMPLANET’s Annual General Meeting Held on April 11, 2025

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth : ALIMP, FR0013470168, éligible PEA-PME), a…

13 hours ago